PAMELA RUIZ: Open Payments
NPI 1760078976 · MOUNTAIN VIEW, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,022 in 76 payments from 18 companies in 2025. Trend: 2023 $585 · 2024 $306 · 2025 $2,022
Food & beverage: $2,022
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 17 | $444 |
| Lundbeck LLC | 9 | $346 |
| Lilly USA, LLC | 8 | $239 |
| ViiV Healthcare Company | 8 | $195 |
| PFIZER INC. | 9 | $172 |
| Exact Sciences Corporation | 5 | $125 |
| ABBVIE INC. | 3 | $93 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $86 |
| Axsome Therapeutics, Inc. | 2 | $55 |
| Gilead Sciences, Inc. | 2 | $51 |
Products named: Ozempic, VYEPTI, APRETUDE, KISUNLA, Wegovy, ELIQUIS, XIFAXAN, REXULTI.
Industry payments across CA — which companies pay providers there.
